Key result
Halothane and isoflurane were associated with similar incidences of respiratory complications in COPD patients, though tachycardia was significantly more frequent with isoflurane.
RCT (n=148)
Randomly assigned
Answers are grounded in this paper and cite their sources.
Neither agent shows respiratory advantage in COPD; tachycardia association with isoflurane warrants confirmation in randomized studies.
Patients with chronic obstructive pulmonary disease (COPD) (N = 148) underwent general anesthesia with halothane (H) or isoflurane (I) each administered randomly to 74 patients. One hundred and ten pre-, intra-, and postoperative variables were analyzed, including outcome variables, which included intra- and postoperative respiratory complications. Univariate computer analyses demonstrated no differences between H and I groups with respect to all variables, the exception being tachycardia, which occurred significantly more frequently in patients given I. Log-linear analyses revealed that no interactions existed between H or I groups, the non-outcome variables, and the complications. We conclude that patients with COPD respond similarly to H and I and that these anesthetics are associated with similar incidences of respiratory complications.
No takes yet. Share an insight, caveat, or question.
Gold et al. (1983) conducted an RCT in Chronic obstructive pulmonary disease (COPD) (n=148). Halothane vs. Isoflurane was evaluated on Intra- and postoperative respiratory complications. Halothane and isoflurane were associated with similar incidences of respiratory complications in COPD patients, though tachycardia was significantly more frequent with isoflurane.
Synapse has enriched 10 related papers. Consider them for comparative context: